An HIV/STI screening and PrEP program for primary care
Part of Immune system & allergy, Infections clinical trials.
This study tests a program that helps primary care clinics offer HIV and STI testing and connect patients to PrEP, a medicine that prevents HIV. It is for adults aged 18 to 45 in specific clinics in Mississippi.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- You get your primary care at a participating health center in Canton or Yazoo City, Mississippi.
- You can read and understand English enough to answer surveys and interviews.
- You are not currently very ill, unstable, or unable to make decisions for yourself.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps connect young people aged 13–24 to PrEP, a daily pill that prevents HIV. It tests whether offering PrEP in clinics or community locations makes it easier for you to get and stay on this prevention medication.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
This study looks at offering HIV prevention medicines (PrEP) to patients visiting a family planning clinic. It aims to make it easier for people to access this care alongside their regular visit.
This study tests a program to help women at risk for HIV get PrEP, a medicine that prevents HIV. It focuses on women who may want to have a child or have been pregnant recently.
This study tests a program called PrEP Choice to help young people learn about and start PrEP, a daily pill that prevents HIV. It aims to see if offering choices in PrEP care makes it easier to use.
This study tests whether offering PrEP counseling to women with a recent STI at family planning clinics helps them start HIV prevention. Women who test positive for syphilis, gonorrhea, or chlamydia may be offered PrEP information and support.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.